Trial
NCT01405846
Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Papworth Hospital NHS Foundation Trust
Collaborators
AstraZeneca; Noble Organisation
Condition
Lung Cancer
Intervention
Gefitinib
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-19